Abstract
Abdominal pain is common in the general population and, in patients with irritable bowel syndrome, is attributed to visceral hypersensitivity. We found that oral administration of specific Lactobacillus strains induced the expression of μ-opioid and cannabinoid receptors in intestinal epithelial cells, and mediated analgesic functions in the gut—similar to the effects of morphine. These results suggest that the microbiology of the intestinal tract influences our visceral perception, and suggest new approaches for the treament of abdominal pain and irritable bowel syndrome.
Access options
Subscribe to Journal
Get full journal access for 1 year
$209.00
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.


References
- 1
Guarner, F. & Malagelada, J.R. Lancet 361, 512–519 (2003).
- 2
Falk, P.G. et al. Microbiol. Mol. Biol. Rev. 62, 1157–1170 (1998).
- 3
Verdu, E.F. et al. Gut 55, 182–190 (2006).
- 4
Kamiya, T. et al. Gut 55, 191–196 (2006).
- 5
Kajander, K. et al. Aliment. Pharmacol. Ther. 22, 387–394 (2005).
- 6
O'Mahony, L. et al. Gastroenterology 128, 541–551 (2005).
- 7
Philippe, D. et al. Gut 55, 815–823 (2006).
- 8
Wright, K. et al. Gastroenterology 129, 437–453 (2005).
- 9
Stein, C. et al. Nat. Med. 9, 1003–1009 (2003).
- 10
Philippe, D. et al. J. Clin. Invest. 111, 1329–1338 (2003).
- 11
D'Argenio, G. et al. FASEB J. 20, 568–570 (2006).
- 12
Bourdu, S. et al. Gastroenterology 128, 1996–2008 (2005).
- 13
Cervero, F. & Laird, J.M.A. Lancet 353, 2145–2148 (1999).
- 14
Sanders, M.E. & Klaenhammer, T.R. J. Dairy Sci. 84, 319–331 (2001).
- 15
Altermann, E. et al. Proc. Natl. Acad. Sci. USA 102, 3906–3912 (2005).
Acknowledgements
We thank the Institut Universitaire de France and Danisco Cultures for their support.
Author information
Affiliations
Contributions
C.R. conducted and performed the in vitro and in vivo experiments. X.T., L.D., C.D. and E.M. contributed to the in vitro and in vivo experiments. M.C. was involved in the Rela−/− experiment. A.G. and D.A. performed colorectal distension in rodents. N.B. and C.N. were involved in the bacteriological experiment. K.G. performed the histological experiments. D.C. was involved in the research proposals and in the coordination of the studies within Danisco research centers. A.C.O. quantified NCFM DNA in the feces using PCR. G.L. validated the taxonomical analysis of the different bacterial species used in this study and performed measurements of Lactobacillus acidophilus NCFM products. J.-F.C. contributed to data discussion and analysis. P.D. designed and supervised the study, and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
P.D. has received funding for research and clinical studies on probiotics and prebiotics from Danisco, Sanofi-Aventis, Syndifrais, Roquette and Lesaffre, and has also received consultation fees from Danisco, Danone and Roquette. In addition, P.D. is an inventor of patents filed by Danisco.
C.N. has received funding for research studies from Danone and Roquette.
D.C., A.O. and G.L. are employed by Danisco, which produces and markets the NCFM strain.
Rights and permissions
About this article
Cite this article
Rousseaux, C., Thuru, X., Gelot, A. et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 13, 35–37 (2007). https://doi.org/10.1038/nm1521
Received:
Accepted:
Published:
Issue Date:
Further reading
-
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat
Epilepsia (2021)
-
Microbiome and substances of abuse
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021)
-
Spinal cord injury and gut microbiota: A review
Life Sciences (2021)
-
Therapeutic potential of cannabinoids in combination cancer therapy
Advances in Biological Regulation (2021)
-
Linking Gut Microbiome and Lipid Metabolism: Moving beyond Associations
Metabolites (2021)